As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...
AbbVie commits to lowering Medicaid drug prices and investing $100 billion in US R&D and capital investments over the next decade. The TrumpRx program will expand direct-to-patient offerings, ...
Connecticut data from 2022 to 2023 show medications from retail pharmacies accounted for the state's highest health care ...
In late 2025, President Donald Trump unveiled a high-profile initiative aimed at tackling one of the most persistent and politically charged issues in American healthcare: sky-high prescription drug ...
President Donald Trump has announced a new initiative aimed at lowering prescription drug costs, unveiling TrumpRx.gov, a website he says will offer Americans access to sharply reduced drug prices ...
A federal judge in Pennsylvania has approved a nearly $60 million settlement with a trio of drug makers who are defendants in a multi-district litigation claiming numerous companies fixed the prices ...
Nov 12 (Reuters) - Plaintiffs in a sweeping antitrust case over generic drug pricing have asked a federal judge to intervene against a group of claims recovery firms they say are misleading class ...
WASHINGTON - Skyrocketing drug costs became the stuff of congressional hearings and presidential campaign speeches in 2015, and not only because of the brash Martin Shkrelis of the world. The federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback